Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Zeo ScientifiX (ZEOX) Common Equity (2016 - 2026)

Zeo ScientifiX (ZEOX) has 14 years of Common Equity data on record, last reported at -$1.4 million in Q4 2025.

  • For Q4 2025, Common Equity rose 13.91% year-over-year to -$1.4 million; the TTM value through Oct 2025 reached -$1.4 million, up 13.91%, while the annual FY2025 figure was -$1.4 million, 13.91% up from the prior year.
  • Common Equity reached -$1.4 million in Q4 2025 per ZEOX's latest filing, up from -$2.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $1.9 million in Q4 2022 and bottomed at -$4.6 million in Q3 2022.
  • Average Common Equity over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2024.
  • Peak YoY movement for Common Equity: surged 170.87% in 2022, then plummeted 1123.02% in 2024.
  • A 5-year view of Common Equity shows it stood at -$2.7 million in 2021, then surged by 170.87% to $1.9 million in 2022, then plummeted by 165.7% to -$1.2 million in 2023, then crashed by 33.2% to -$1.7 million in 2024, then grew by 13.91% to -$1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were -$1.4 million in Q4 2025, -$2.3 million in Q3 2025, and -$2.1 million in Q2 2025.